Effect of relaxation on Death Anxiety and Hope
Phase 3
- Conditions
- Breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20170610034435N8
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Breast Cancer
Ability to communicate in Persian
History of taking anti-anxiety medications
History of participation in training courses (before and during the research)
Exclusion Criteria
History of neurologic and musculoskeletal disorders, auditory problems, and drug abuse
Unwillingness to continue and lack of cooperation at any time of study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death anxiety. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Templar death anxiety inventory.
- Secondary Outcome Measures
Name Time Method Hope. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Herth hope questionnaire.;Death anxiety. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Templer death anxiety questionnaire.